Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 2 | 0 | 0 | 0 |
| Receivables | 25 | N/A | 0 | 0 | 0 |
| Other current assets | 19 | 54 | 0 | 0 | 0 |
| TOTAL | $47 | $104 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $0 | $N/A | $N/A | $N/A |
| Total Assets | $47 | $104 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,382 | 1,366 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 169 | 159 | 0 | 0 | 0 |
| Accrued Expenses | 306 | 137 | 0 | 0 | 0 |
| TOTAL | $2,165 | $2,083 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,165 | $2,083 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -15,017 | -14,875 | 0 | 0 | 0 |
| Other shareholders' equity | -1,430 | -1,428 | 0 | 0 | 0 |
| TOTAL | $-2,118 | $-1,979 | $0 | $0 | $0 |
| Total Liabilities And Equity | $47 | $104 | $0 | $0 | $0 |